ASX - Delayed Quote AUD

Nanollose Limited (NC6.AX)

Compare
0.0410
-0.0010
(-2.38%)
At close: 11:24:30 AM GMT+11
Loading Chart for NC6.AX
  • Previous Close 0.0420
  • Open 0.0410
  • Bid 0.0410 x --
  • Ask 0.0420 x --
  • Day's Range 0.0410 - 0.0410
  • 52 Week Range 0.0160 - 0.0440
  • Volume 190,208
  • Avg. Volume 290,707
  • Market Cap (intraday) 9.778M
  • Beta (5Y Monthly) -0.01
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Feb 20, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre for use in textiles; Jelli Grow, an alternative seed germination and plant growing material; and Nufolium that is used for nonwoven applications, such as wipes. It also offers Biollose, a soilless growing media; and MicroGel, which is developed specifically for the commercial microgreens market. Nanollose Limited The company was incorporated in 2014 and is based in Nedlands, Australia.

www.nanollose.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: NC6.AX

View More

Performance Overview: NC6.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

NC6.AX
115.79%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

NC6.AX
70.83%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

NC6.AX
62.73%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

NC6.AX
51.06%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: NC6.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NC6.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    9.54M

  • Enterprise Value

    9.43M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    263.59

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    306.09

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -112.34%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    16.63k

  • Net Income Avi to Common (ttm)

    -1.37M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    405.01k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -366.95k

Research Analysis: NC6.AX

View More

Company Insights: NC6.AX

Research Reports: NC6.AX

View More

People Also Watch